Treatment of Irritability in ASD: Risperidone and Aripiprazole
Abstract
Risperidone and aripiprazole are FDA approved for treating irritability in children and adolescents with ASD. Metabolic side effects are common when prescribing antipsychotics for irritability in ASD. Antipsychotic-induced weight gain in patients with ASD can be attenuated by adding metformin.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.